info@PremierEndpoint.com (914) 315-9334
US Survey Data

The rising cost of medicines may be a growing problem for many Americans, but a new survey finds that cost is generally not a key factor when doctors decide which treatments to prescribe their patients. Among six different types of doctors queried, only primary care physicians cited cost as among their most important considerations. Forty-seven […]

Oncology

A comparison of current practice patterns of US dermatologists versus published guidelines for the biopsy, initial management, and follow up of patients with primary cutaneous melanoma https://www.ncbi.nlm.nih.gov/pubmed/27742167 The American Academy of Dermatology and others have formulated guidelines for the management of melanoma. Aaron S. Farberg, MD and Darrell S. Rigel, MD conducted a study to […]

US Survey Data
Healthcare Disparities in Hispanic Diabetes Care
October 14, 2016

Healthcare Disparities in Hispanic Diabetes Care: A Propensity Score-Matched Study. Lai LL, Alfaifi A, Althemery A. J Immigr Minor Health. 2016 Sep 26. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/27669718 The Hispanic population is the nation’s largest minority. Hispanic ethnic group represents 15 % of the U.S. population; if current demographic trends continue, this group’s growth will […]

Unmet Needs

Predicting Inadequate Response to Acute Migraine Medication: Results From the American Migraine Prevalence and Prevention (AMPP) Study https://www.ncbi.nlm.nih.gov/pubmed/27731896 Selecting optimal treatments for migraine to improve acute treatment outcomes in population samples requires knowledge of headache characteristics that predict success and failure of acute therapy. Pain freedom at 2 hours and sustained pain response at 24 […]

US Survey Data
New myeloproliferative neoplasm (MPN) survey data
October 10, 2016

First study in the myeloproliferative neoplasm (MPN) setting to evaluate discordance in communication and perceptions between US patients and physicians. Differences in treatment goals and perception of symptom burden between patients with myeloproliferative neoplasms (MPNs) and hematologists/oncologists in the United States: Findings from the MPN Landmark survey. Mesa RA, et al. Cancer. 2016 Sep 30. […]